Millicurie to Microcurie

Yes, and it creates real problems. If a patient who received therapeutic I-131 (30–200 mCi) dies within days, the body can trigger radiation alarms at funeral homes and crematoria. Cremation is the bigger concern — burning the body aerosolises the isotope, contaminating the crematorium and potentially exposing workers. Most radiation safety programs require a waiting period before cremation, or direct burial with notification to the funeral director. In 2019, an Arizona crematorium unknowingly cremated a patient with residual lutetium-177, contaminating the facility. Hospitals are supposed to flag these cases, but the system is imperfect.

The radiopharmacist draws the Tc-99m solution into a syringe, places it in a dose calibrator (a pressurized argon ionisation chamber), and reads the activity in mCi or MBq. Because the isotope is decaying constantly — Tc-99m loses half its activity every 6 hours — the calibrator reading must be decay-corrected to the planned injection time. If the scan is at 2pm and the dose is drawn at 10am, the pharmacist dispenses more than the prescribed 20 mCi, knowing it will decay to exactly 20 mCi by injection. Timing is everything.

The Tc-99m bone scan, with about 20–25 mCi (740–925 MBq) injected intravenously. Technetium-99m accumulates in areas of high bone turnover — fractures, infections, metastases — and emits 140 keV gamma rays that a gamma camera images. The scan itself takes 2–3 hours (allowing time for the tracer to distribute), and the patient's radioactivity drops to negligible levels within 24–48 hours. Over 30 million Tc-99m procedures are performed worldwide each year, making it by far the most-used medical radioisotope.

Technically yes, but radiation detectors at airports, borders, and government buildings may alarm for days after certain scans. A patient who received 10 mCi of I-131 can trigger a portal monitor for up to 3 months. Most nuclear medicine departments provide a wallet card explaining the procedure, isotope, and date — TSA and customs agents are trained to recognize these. The actual radiation risk to fellow passengers is negligible; the issue is entirely about security system sensitivity, not safety.

Hyperthyroidism treatment aims to kill just enough thyroid tissue to normalize hormone production — typically 5–15 mCi (185–555 MBq) of I-131. Thyroid cancer ablation aims to destroy every remaining thyroid cell after surgery and kill any metastases — that takes 30–200 mCi (1.1–7.4 GBq). The higher doses require inpatient isolation and more aggressive radiation safety precautions. Some oncologists are exploring whether lower ablation doses (30 mCi) work as well as high ones (100+ mCi) for low-risk cancers — the evidence is surprisingly close.

Because microcuries are the threshold where regulatory accountability begins for most isotopes. A lab ordering 250 µCi of P-32 must log the receipt, track usage, survey for contamination weekly, monitor personnel doses, and account for every fraction disposed of or decayed. Multiply that by dozens of labs across a campus, each using different isotopes with different rules, and you get a full-time radiation safety program. The obsession is not about the hazard of any single vial — it is about preventing the slow accumulation of untracked material that eventually leads to a contamination incident or regulatory violation.

It depends on what the isotope emits. A 100 µCi tritium source needs no shielding at all — the beta particles cannot penetrate a sheet of paper. A 100 µCi phosphorus-32 source (high-energy beta) needs about 1 cm of acrylic to stop the betas, but acrylic is preferred over lead because lead produces bremsstrahlung X-rays from energetic betas. A 100 µCi caesium-137 source (gamma emitter) needs a thin lead container. At microcurie levels the shielding is lightweight and portable — nothing like the heavy lead pigs used for millicurie medical sources.

Most check sources contain 0.1–1 µCi of caesium-137, chosen because Cs-137 has a convenient 662 keV gamma ray and a 30-year half-life — long enough that the source maintains predictable activity for decades without frequent recalibration. The activity is high enough to produce a clear above-background reading (several hundred counts per minute) but low enough to be exempt from most transport regulations. Technicians hold the check source near the detector before each use to verify the instrument is responding. If the reading is off by more than 10–20% from the expected value, the instrument goes back for calibration.

Not from external exposure — the dose rates are far too low. At 1 meter from a 500 µCi unshielded Cs-137 source, the dose rate is about 1.6 µSv/hr, which is only a few times background. The danger from microcurie quantities comes from internal exposure: inhaling or ingesting even micrograms of an alpha emitter like polonium-210 or americium-241 can deliver a concentrated dose to lung or gut tissue. Alexander Litvinenko was killed by roughly 26 µCi of Po-210 dissolved in tea — a quantity invisible to the eye.

Autoradiography uses radioactive decay to make an image — you label DNA or protein with P-32, separate the molecules on a gel, press the gel against X-ray film or a phosphor screen, and the beta particles expose the film wherever your target molecule sits. A typical experiment uses 50–250 µCi, which gives a visible image in hours to overnight. P-32 is favored because its high-energy beta (1.7 MeV) produces sharp, high-contrast bands without the weeks-long exposure times that weaker emitters like S-35 or C-14 require.